SYRE Cash Conversion Ratio

Spyre Therapeutics Inc · Cash Conversion Ratio

SYRE logo

SYRE Cash Conversion Ratio

Current (TTM)1.17×
SYRE Cash Conversion Ratio (0.99× → 1.17×)
High-resolution chart · PNG

SYRE cash conversion ratio history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Spyre Therapeutics Inc Cash Conversion Ratio — Annual fiscal periods
Period endingCash Conversion Ratio
0.2949×
0.9567×
0.825×
0.7354×
0.9265×
0.8781×
0.9907×
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.